So what have the trials shown us?
All 5 Oxaliplatain trials used low dose
oxaliplatin as a radiosensitizer with CRT
2 trials mandated oxaliplatin also as
postoperative adjuvant (so if benefit which
component?)
Some of the 5 trials did not mandate TME
(NB the German trial did)